Fennec Pharmaceuticals (NASDAQ: FENC) reported Q1 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $8.1 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.